Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|899-1987|10|1194-1204

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.899-1987, Iss.10, 2015-10, pp. : 1194-1204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 1194-1204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Defective autophagy is a key feature of cerebral cavernous malformations

By  

EMBO Molecular Medicine, Vol. 7, Iss. 11, 2015-11 ,pp. : 1403-1417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 319-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolite of ellagitannins, urolithin A induces autophagy and inhibits metastasis in human sw620 colorectal cancer cells

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 193-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1172-1180

John Wiley & Sons Inc

Access to resources Recommend Favorite